Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Becker

Showing results (151-160 of 194) with videos related to

Pageof 20
Sort By:
European Journal of Immunology|March 27, 2001
In situ cytokine therapy: redistribution of clonally expanded T cellsP thor Straten, P Guldberg, D Schrama, et al.
British Journal of Cancer|October 10, 2002
Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2J C Becker, P Terheyden, E Kämpgen, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2000
Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro cultureP thor Straten, A F Kirkin, E Siim, et al.
Leukemia|October 1, 2010
COX-2 is a novel target in therapy of mycosis fungoidesK L M Kopp, S Dabelsteen, T Krejsgaard, et al.
The British Journal of Dermatology|January 31, 2012
P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survivalL Vlahova, Y Doerflinger, R Houben, et al.
Biochimica Et Biophysica Acta|July 9, 1999
Expression of constitutive nitric oxide synthase in rat and human gastrointestinal tractH Fischer, J C Becker, P Boknik, et al.
Leukemia|August 26, 2006
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphomaT Krejsgaard, C S Vetter-Kauczok, A Woetmann, et al.
The Journal of Cell Biology|February 1, 1996
Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3A M Montgomery, J C Becker, C H Siu, et al.
Annals of the Rheumatic Diseases|October 9, 2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapyM C Genovese, M Schiff, M Luggen, et al.
International Journal of Cancer|December 18, 2001
Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progressionM H Andersen, P Keikavoussi, E B Bröcker, et al.
Pageof 20

Showing results (151-160 of 194) with videos related to

Sort By:
Pageof 20
European Journal of Immunology|March 27, 2001
In situ cytokine therapy: redistribution of clonally expanded T cellsP thor Straten, P Guldberg, D Schrama, et al.
British Journal of Cancer|October 10, 2002
Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2J C Becker, P Terheyden, E Kämpgen, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2000
Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro cultureP thor Straten, A F Kirkin, E Siim, et al.
Leukemia|October 1, 2010
COX-2 is a novel target in therapy of mycosis fungoidesK L M Kopp, S Dabelsteen, T Krejsgaard, et al.
The British Journal of Dermatology|January 31, 2012
P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survivalL Vlahova, Y Doerflinger, R Houben, et al.
Biochimica Et Biophysica Acta|July 9, 1999
Expression of constitutive nitric oxide synthase in rat and human gastrointestinal tractH Fischer, J C Becker, P Boknik, et al.
Leukemia|August 26, 2006
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphomaT Krejsgaard, C S Vetter-Kauczok, A Woetmann, et al.
The Journal of Cell Biology|February 1, 1996
Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3A M Montgomery, J C Becker, C H Siu, et al.
Annals of the Rheumatic Diseases|October 9, 2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapyM C Genovese, M Schiff, M Luggen, et al.
International Journal of Cancer|December 18, 2001
Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progressionM H Andersen, P Keikavoussi, E B Bröcker, et al.
Pageof 20